
New findings on the connection between confidence and aesthetics
In the Triangle's competitive professional landscape, confidence isn't just a feeling — it's a catalyst for success. Raleigh-based Merz Aesthetics, a global medical aesthetics business, recently unveiled the results of their ground breaking study, Pillars of Confidence: Global Insights on Aesthetics and Self-Affirmation revealing how aesthetic treatments can help align our inner selves with our outward appearance to support self-confidence.
Inspired by a purpose to fuel confidence worldwide, Merz Aesthetics undertook this research to spark a new conversation around confidence and the higher-order benefits of aesthetic treatments, grounded in data from 15,000 adults across 15 countries (approximately 1,000 participants per country including the United States).
The impact on self-perception
Merz Aesthetics' research delves into a key question: How do aesthetic treatments impact confidence and self-perception? The findings are illuminating:
74% of U.S. respondents agreed with the statement, "I am confident in who I am."
64% said they use aesthetic treatments to create a look inspired by how they feel inside.
68% reported that treatments impacted how they view themselves.
The research shows what many may have already intuited — aesthetic treatments seem to do more than just enhance appearance; they can help people feel empowered as they embark on their self-confidence journey.
Regional relevance and broader implications
In a region that's frequently ranked among the best places to live and work, businesses could certainly benefit from gaining a better understanding of the role confidence plays in daily life. The Pillars of Confidence study shows that people who feel confident are more likely to embrace new experiences, pursue opportunities and create relationships. Imagine what that could mean for the Triangle's workforce, where attracting top talent, making professional connections and fostering creativity are already top priorities.
These broader benefits are validated by the study's findings. Seventy-five percent of U.S. respondents believe that developing self-confidence is important to one's well-being. When it comes to individual benefits, 69% of U.S. respondents said aesthetic treatments impact their confidence in social situations and 53% agreed that treatments affect their overall outlook on life.
Navigating age perception in the workplace
The research also explores evolving sentiments around aging, making it particularly relevant in our multi-generational workplaces. The Pillars of Confidence study found that, while there are many factors that contribute to people's confidence levels in the workplace, age perception holds a notable amount of influence. In fact, 48 percent of U.S. respondents don't want to be perceived as older than they are and a majority (71%) seek treatments to manage the signs of aging.
A cultural shift toward openness
One of the key insights from the study is an increasing openness around aesthetics. Fifty-five percent of U.S. respondents said they were comfortable discussing treatments, while fewer than 38% feared judgment. This represents a cultural shift toward authenticity that businesses can embrace by creating spaces — both physical and digital — where people feel comfortable and supported in their unique self-confidence journeys.
Transformative effects on personal empowerment
The higher-order impact of aesthetic treatments is striking. After receiving them:
68% of U.S. respondents felt more empowered.
62% said they felt more alive.
54% felt ready to embrace new experiences.
For Triangle employers, these findings suggest that supporting employee confidence — however they choose to cultivate it — may yield benefits in workplace engagement and innovation.
Read more about the Pillars of Confidence Study and get access to the global and regional reports at merzaesthetics.com/confidence.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
25 minutes ago
- Associated Press
Zeteo Biomedical Secures Global Patents for Nasal and Ophthalmic Drug Delivery Device Innovations
CEDAR PARK, Texas, June 11, 2025 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical, a privately held biomedical device company, today announced the issuance of new patents in the United States and European Union for its advanced drug delivery technologies. The patents, titled 'Cartridge Devices for Administration of a Medicament' (U.S. Patent No. 12329949) and 'Hand-Operated Devices for Administration of a Medicament' (EU Patent No. 3946526), further strengthen Zeteo's ZTech™ delivery platform portfolio for the administration of drugs and biologics via nasal, ophthalmic, and sublingual routes. These patented innovations advance Zeteo's ZTech-L™ and ZTech-P™ delivery systems, which include both single-use disposable and multi-dose, cartridge-reloadable handheld devices. The platforms support the administration of therapeutics in both liquid and dry powder formulations, including vaccines, biologics, and specialty drugs. Nasal delivery, in particular, is emerging as a highly effective, non-invasive alternative for treating conditions such as pain, emesis, seizures, neurodegenerative and autoimmune disorders, infectious diseases, and bioterror threats. 'We are seeing increasing global demand for metered-dose nasal, ophthalmic, and sublingual delivery devices that are compact, intuitive, and suitable for self-administration,' said Timothy Sullivan, CEO of Zeteo Biomedical. 'A unique feature that sets our device technology apart is its ability to function reliably in any physical orientation, making it ideal for medication delivery in both terrestrial and space-based microgravity environments. This capability opens exciting new frontiers for Zeteo including applications in space-based healthcare.' Zeteo's integrated delivery platforms and technical services streamline the development and commercial-scale production of patient-centric drug/device combination products for pharmaceutical and biotech partners. This focus on patient-friendly design improves treatment adherence and medical outcomes, while enhancing product differentiation and brand value for manufacturers. Zeteo's platform technologies are designed to meet the evolving demands of global and interstellar healthcare markets, delivering precision, performance, and portability for the next-generation of therapeutic drug/device combination products. About Zeteo Biomedical LLC Zeteo Biomedical is a Texas-based medical device company focused on the development and commercialization of advanced drug and biologic delivery systems. The company specializes in intranasal, ophthalmic, and sublingual delivery technologies designed to improve patient outcomes through precision dosing, portability, and ease of use. Zeteo's proprietary platforms are supported by an extensive patent portfolio and a range of product development services tailored to accelerate time to market for pharmaceutical and biotech clients worldwide. To learn more, visit MEDIA CONTACT: Cathy Diehl Zeteo Biomedical LLC +(1) 512-614-0144 [email protected] *LOGO link for media: NEWS SOURCE: Zeteo Biomedical LLC Keywords: Biotechnology, Zeteo Biomedical, drug delivery, vaccines, med tech, pharmaceuticals, biotech, public health, Nasal and Ophthalmic Drug Delivery Device, CEO Timothy Sullivan, CEDAR PARK, Texas This press release was issued on behalf of the news source (Zeteo Biomedical LLC) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P126872 APNF0325A To view the original version, visit: © 2025 Send2Press® Newswire, a press release distribution service, Calif., USA. RIGHTS GRANTED FOR REPRODUCTION IN WHOLE OR IN PART BY ANY LEGITIMATE MEDIA OUTLET - SUCH AS NEWSPAPER, BROADCAST OR TRADE PERIODICAL. MAY NOT BE USED ON ANY NON-MEDIA WEBSITE PROMOTING PR OR MARKETING SERVICES OR CONTENT DEVELOPMENT. Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.
Yahoo
an hour ago
- Yahoo
Cuts to Medicaid for Ohioans with disabilities could take away home care and job help
(iStock / Getty Images Plus) As the Ohio Senate moves forward with its budget proposal, advocates for Medicaid are hoping changes can be made to avoid significant impacts to low income residents, elderly Ohioans, and people with disabilities. Funding from Medicaid allows 3 million Ohioans access to health care services, including more than 770,000 who receive them through the Medicaid expansion program instituted in 2014. That expansion program allows people who weren't eligible for the traditional Medicaid programs but were still in categories of need to access health care. The existence of that program dropped the uninsured rate in Ohio to historic levels, according to the Health Policy Institute of Ohio. Along with health care, Medicaid dollars help with services that aren't necessarily connected to medical treatment, like home care, employment help, transportation, and a direct care provider who helps with all of those things. 'In many cases, if there wasn't Medicaid dollars behind it, I know of many people whose ability to live outside of a hospital or in the community would be threatened,' said Jules Patalita, a disability rights advocate for Sylvania-based The Ability Center. So advocates were disappointed to see the Ohio Senate maintain a provision from both the Ohio House's and Gov. Mike DeWine's budget proposals that would eliminate the Medicaid expansion group if the federal government reduces their level of support (currently at 90%) by even 1%. 'This would be a substantial loss for many working Ohioans,' said Kathryn Poe, researcher for the think tank Policy Matters Ohio. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX Also included in the Senate's budget proposal is the elimination of a Medicaid waiver that 'would have provided continuous coverage for kids up to age 3,' Poe said, and a separate section of the budget that would 'allow the state to pause, eliminate or change other funds related to all other federal grants, should Congress adjust or eliminate funding for that program.' Poe did praise the Senate proposal for removing a House-submitted provision limiting Medicaid reimbursement for doulas to only six Ohio counties. 'This will ensure that Ohio parents continue to have access to culturally appropriate birthing resources and management,' Poe said. Concerns about loss of access don't just extend to physical health concerns or daily home services, but also to behavioral health services, on which 47% of Ohio adults on Medicaid rely, according to Kerstin Sjoberg, president and CEO of Disability Rights Ohio. 'If you don't have access to some sort of insurance like Medicaid, it's going to be almost impossible to get those services,' Sjoberg said. The state-level discussions come as federal budget reconciliation also touches on Medicaid funding as the Trump administration and Republicans in Congress attempt to slash federal spending by $880 billion over the next decade, particularly from public assistance programs like the Supplemental Nutrition Assistance Program (SNAP) and Medicaid. U.S. House Speaker Mike Johnson and other leaders have talked about 'abuse' or 'fraud' as sources of revenue loss for the country in public programs, something those who engage with users of programs like Medicaid push back on. 'In reality, Medicaid is one of the most cost-effective and widely used safety nets in the country,' said the advocacy group Innovation Ohio in a call-to-action email over the congressional budget proposals. 'If this bill becomes law, the result will be fewer people with health care, more families pushed into poverty and deeper inequality. Rural hospitals could shut down.' According to a study by the Commonwealth Fund, Ohio could be one of the hardest hit economies if Medicaid cuts at the federal level come to fruition, cuts that could mean 29% more Medicaid spending by states or cuts to other programs, like education, to offset the Medicaid losses. One thing that will have to be addressed whether or not the cuts are realized in the state and federal budgets is the workforce that helps those who use Medicaid for home care and other services. Patalita said the word 'crisis' has been used in talking about the shortage of direct care providers, similar to the shortage of child care workers needed to provide adequate access to that service. 'We've talked to people who have had to wait weeks to be able to receive services in the home, because there just aren't enough providers out there,' Patalita said. The Ability Center did a study after the previous state budget increased the reimbursement rate for direct care providers under the state Medicaid program. That study showed that while reimbursements rates and, for that matter, provider wages should go up, the solution to the shortage problem wouldn't come with just one answer. 'The direct care crisis is too complex of an issue for a single action to remedy,' The Ability Center found. The study identified three 'major elements' of the shortage: high turnover rates, low hourly wages (lower than 'many entry level positions in retail and food service,' according to the study), and a lack of consistency in benefits. 'This failure by agencies to provide benefits adds to the worker shortage and forces those requiring home care to carry the burden of decreased access to care, especially those in rural areas,' the study found. Eliminating Medicaid funding, including the expansion group, will make life harder for those Ohioans who need the services, Sjoberg said, 'but it will also make it necessary that the direct care workforce is supported in other ways.' SUPPORT: YOU MAKE OUR WORK POSSIBLE
Yahoo
an hour ago
- Yahoo
Aldi Recall Alert: Hidden Allergens in Two Products Sold in 16 States
If you've shopped at Aldi recently, it might be time to double-check your freezer. The budget grocery giant has issued two new food recalls affecting 16 states. The recall comes after potential allergen risks were discovered in products sold under its private label brands. The first recall involves Casa Mamita Churro Bites Filled with Chocolate Hazelnut Cream. According to the U.S. Food and Drug Administration, the product may contain undeclared milk, a major allergen. The affected churro bites come in 7.05-ounce cardboard boxes marked with UPC Code 4061459561807 and a "Best If Used By" date of July 14, 2026. While no illnesses have been reported, customers with milk allergies are advised not to consume the product and instead return it to Aldi for a full refund. This product was distributed in 13 states: Alabama, Arkansas, Florida, Georgia, Iowa, Illinois, Kentucky, Louisiana, Missouri, Mississippi, North Carolina, South Carolina, and Tennessee. The second recall affects Atlantic Salmon Portions with Seafood Stuffing, manufactured by Santa Monica Seafood. This item was sold in 16-ounce packages with UPC Code 4061459716313 and a use/freeze-by date of June 2, 2025. It was distributed to Aldi locations in California, Nevada, and Arizona. The product may contain undeclared soy, another top allergen that can cause serious reactions for sensitive individuals. For customers with food allergies, these undeclared ingredients pose a serious health risk. Dr. Sebastian Lighvani, a New York-based allergist, explained to Newsweek that even trace amounts of allergens like milk or soy can trigger immune responses in susceptible individuals. They could lead to potentially life-threatening reactions. Aldi emphasized its commitment to consumer safety in a statement, directing concerned customers to their recall page and offering full refunds on returned products. Whether you have known allergies or not, it's worth taking a moment to check your fridge and freezer. Recalls like these are a reminder of how vital food labeling and consumer awareness are, especially when it comes to the ingredients we can't see. Aldi Recall Alert: Hidden Allergens in Two Products Sold in 16 States first appeared on Men's Journal on Jun 11, 2025